Article info
Clinical and epidemiological research
Extended report
Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis
- Correspondence to Dr Kaleb Michaud, 986270 Nebraska Medical Center, Omaha, NE 68198, USA; kmichaud{at}unmc.edu
Citation
Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis
Publication history
- Received May 24, 2016
- Revised October 19, 2016
- Accepted October 21, 2016
- First published November 11, 2016.
Online issue publication
November 02, 2019
Article Versions
- Previous version (2 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/